ELI LILLY & Co

Insider Reports History

Location
Lilly Corporate Ctr, Drop Code 1094, Indianapolis, IN
Signature
/s/ Anat Ashkenazi, Executive Vice President and Chief Financial Officer, on behalf of Eli Lilly and Company
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ELI LILLY & Co:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sigilon Therapeutics, Inc. 10%+ Owner Common Stock 100 $1.49K $14.92 Aug 11, 2023 Direct

Insider Reports Filed by ELI LILLY & Co

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGTX Sigilon Therapeutics, Inc. Aug 11, 2023 1 $25.6M 4 Aug 14, 2023 10%+ Owner
SGTX Sigilon Therapeutics, Inc. Jun 28, 2023 0 $0 3 Jul 7, 2023 10%+ Owner